| scholarly article | Q13442814 |
| P50 | author | Ahmad R. Dehpour | Q37383287 |
| P2093 | author name string | Ethan A Lerner | |
| Sattar Ostadhadi | |||
| Ehsan Azimi | |||
| P2860 | cites work | CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids | Q24556619 |
| Co-expression of the voltage-gated potassium channel Kv1.4 with transient receptor potential channels (TRPV1 and TRPV2) and the cannabinoid receptor CB1 in rat dorsal root ganglion neurons | Q28255982 | ||
| Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment | Q30320295 | ||
| Frontiers in pruritus research: scratching the brain for more effective itch therapy | Q30477216 | ||
| TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms | Q30488724 | ||
| The cells and circuitry for itch responses in mice | Q30540260 | ||
| Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin | Q30955557 | ||
| The mechanism of histamine secretion from gastric enterochromaffin-like cells. | Q33774762 | ||
| Neurochemistry and neuropharmacology of emesis - the role of serotonin | Q34088863 | ||
| Clinical practice. Nausea and vomiting in pregnancy | Q34143187 | ||
| Kappa opioid agonists suppress chloroquine-induced scratching in mice | Q34357890 | ||
| Specific C-receptors for itch in human skin. | Q34441021 | ||
| Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement | Q34451391 | ||
| Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV) | Q34775395 | ||
| Histamine in the nervous system | Q34795903 | ||
| Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner | Q35048297 | ||
| TRP Channels in the Digestive System | Q35177823 | ||
| H1-receptors: localization and role in airway physiology and in immune functions | Q35552822 | ||
| A role for nociceptive, myelinated nerve fibers in itch sensation | Q35557581 | ||
| Plant, synthetic, and endogenous cannabinoids in medicine | Q36366922 | ||
| Motion sickness susceptibility | Q36576342 | ||
| TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells | Q37117587 | ||
| TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis | Q37118783 | ||
| Emerging strategies for exploiting cannabinoid receptor agonists as medicines | Q37230665 | ||
| Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives | Q37491434 | ||
| Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting | Q37517566 | ||
| Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease | Q37593097 | ||
| Tachykinin receptor antagonists in clinical trials | Q37638682 | ||
| Substance P induces degranulation of mast cells and leukocyte adhesion to venular endothelium | Q71358442 | ||
| Neuropeptides in the skin of patients with atopic dermatitis | Q71655870 | ||
| Responses of neurons of canine area postrema to neurotransmitters and peptides | Q72568673 | ||
| Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters | Q72640334 | ||
| Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice | Q73315533 | ||
| Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice | Q74608568 | ||
| Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice | Q77223655 | ||
| Paroxetine for pruritus in advanced cancer | Q77297838 | ||
| Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract | Q79226261 | ||
| Treatment of pruritus with topically applied opiate receptor antagonist | Q79826087 | ||
| TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase | Q79847967 | ||
| Association of a mutation in TRPV3 with defective hair growth in rodents | Q79956183 | ||
| Characterization of sensations induced by capsaicin in the upper gastrointestinal tract | Q80054777 | ||
| The role of selected neuropeptides in pathogenesis of atopic dermatitis | Q80529866 | ||
| Cutaneous manifestations of the malignant carcinoid syndrome | Q81288780 | ||
| Topical aprepitant in clinical and experimental pruritus | Q84842302 | ||
| S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission | Q86836741 | ||
| Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting | Q37857329 | ||
| Distribution, properties, and functional characteristics of three classes of histamine receptor | Q37885674 | ||
| Nalfurafine hydrochloride for the treatment of pruritus | Q38015897 | ||
| Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review. | Q38036613 | ||
| Molecular signaling and targets from itch: lessons for cough | Q38089979 | ||
| Understanding the pathophysiology of itch | Q38095597 | ||
| Histamine H₄ receptors in the gastrointestinal tract. | Q38264340 | ||
| TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch | Q38573328 | ||
| Transient receptor potential ankyrin 1 (TRPA1) channel activation by the thienopyridine-type drugs ticlopidine, clopidogrel, and prasugrel | Q39014728 | ||
| A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch | Q39397866 | ||
| Flare and Itch Induced by Substance P in Human Skin | Q39511292 | ||
| Opioid-induced nausea and vomiting | Q39594607 | ||
| Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. | Q40004812 | ||
| Substance P provokes cutaneous erythema and edema through a histamine-independent pathway | Q41092115 | ||
| Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. | Q42844756 | ||
| Restriction of transient receptor potential vanilloid-1 to the peptidergic subset of primary afferent neurons follows its developmental downregulation in nonpeptidergic neurons | Q42848498 | ||
| Aprepitant as an antipruritic agent? | Q43268400 | ||
| Why are substance P(NK1)-receptor antagonists ineffective in pain treatment? | Q44027293 | ||
| Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects | Q44066940 | ||
| Possible roles of epidermal opioid systems in pruritus of atopic dermatitis | Q44335642 | ||
| Mirtazapine for pruritus | Q44340894 | ||
| Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract | Q44377227 | ||
| Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial | Q44679061 | ||
| Involvement of substance P in scratching behaviour in an atopic dermatitis model | Q44894289 | ||
| The action of histamine on the isolated stomach muscle of the cat. | Q45220992 | ||
| Phospholipase Cbeta 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons | Q46300049 | ||
| Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice. | Q46406522 | ||
| A controlled trial of ondansetron in the pruritus of cholestasis | Q46424983 | ||
| Neuropeptides activate human mast cell degranulation and chemokine production | Q46961068 | ||
| TRPV3 as a therapeutic target for itch | Q48172488 | ||
| Vagal afferent innervation of the gastrointestinal tract | Q48392322 | ||
| The impact of pruritus on quality of life: the skin equivalent of pain. | Q48647840 | ||
| Association of stress with symptoms of atopic dermatitis | Q48768503 | ||
| Expression and distribution patterns of Mas-related gene receptor subtypes A-H in the mouse intestine: inflammation-induced changes. | Q54267943 | ||
| Vascular reactions of the skin to injury: Part VIII. The resistance of the human skin to constant currents, in relation to injury and vascular response. | Q54757390 | ||
| Peripheral Neuronal Mechanism of Itch | Q54968415 | ||
| A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord | Q56658739 | ||
| Aprepitant plus Ondansetron Compared with Ondansetron Alone in Reducing Postoperative Nausea and Vomiting in Ambulatory Patients Undergoing Plastic Surgery | Q57834664 | ||
| Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin | Q60678303 | ||
| Identification of the populations of enteric neurons that have NK1 tachykinin receptors in the guinea-pig small intestine | Q60733568 | ||
| Sertraline as a first-line treatment for cholestatic pruritus | Q61480066 | ||
| Topische Cannabinoidagonisten | Q62073553 | ||
| Histamine receptors in the isolated rat stomach fundus and rabbit aortic strips | Q67558582 | ||
| Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis | Q67570520 | ||
| Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret | Q70514349 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 340-343 | |
| P577 | publication date | 2016-01-06 | |
| P1433 | published in | Experimental Dermatology | Q15749509 |
| P1476 | title | Are itch and scratching the nausea and vomiting of skin? | |
| P478 | volume | 25 |
Search more.